Brian Hess, CEO of RevBio, joins our GS MedTech Podcast to discuss Tetranite - their bone adhesive biomaterial that bonds, load-bears, and regenerates bone simultaneously.
Brian shares how RevBio secured over $20M in non-dilutive NIH grant funding, why they started with cranial flap fixation as their beachhead indication, and how they're advancing 7 indications in parallel, with 4 already in human trials. He also breaks down how to pitch a platform company to institutional investors, and what a future exit could look like for RevBio.
